KLRC1 and acute myeloid leukemia: The patients diagnosed with AML (85 recipients, 42.5% of all patients) characterized with decreased frequency of NKG2A rs7301582 T allele when compared to donor group (35.29% vs 50.96%, p=0.039) (Figure 2).